
Trevigen Cell Assays (TCA), a division of Trevigen, Inc., was established in 2008 to conduct contract research work for the pharmaceutical, biotechnology, government and academic segments of the medical research market. TCA specializes in designing and conducting assays for lead compounds and genotoxic screening based on DNA damage and repair as well as cancer cell behavior.
| TCA Service: |
Assay |
Applications: |
| CometAssay® | Rapid analysis of DNA fragmentationassociated with DNA damage. |
• Detect and quantitate DNA damage • Follow DNA repair |
| PARP Assay | Measurement of the biotinylatedpoly(ADP-ribose) incorporation onto histone proteins. |
• Assay inhibitors and activators of PARP activity • Determination of IC50 values for PARP inhibitors |
| PARG Assay | Measurement of the loss of biotinylated PAR from histones. | • Identify inhibitors and activators of PARG activity • Determination of IC50 values for PARG inhibitors |
| Pharmacodynamic PARP AssayII |
Measurement of net PAR levels in cellular extracts and tumor lysates. | • Quantification of PAR in peripheral blood mononuclear cells, tissue culture cells, and tumor lysates from different tissues, organs and xenografts • Monitoring the efficacy of PARP inhibitors on PAR formation in vivo • Facilitating development of PARP and PARG targeted therapeutics |
| Cell Invasion Assay | Analysis of responses to chemokines, toxins, drugs and other analytes of interest. | Screening for compounds that influence cellular invasion through: • Extracellular matrices • Angiogenesis • Immune responses • Tumor cell metastasis |
| Cultrex® Cell Invasion and Migration Assays | |
| Comet Assay | |
| HT PARP in vivo Pharmacodynamic Assay | |
| PARP Cell Assays Services |
For more information contact us at TCA@trevigen.com or 1-800-873-8443